¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"nuclear inclusion bodies"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cytoplasmic inclusion body
    ¼¼Æ÷ÁúÆ÷ÇÔü, ¼¼Æ÷ÁúºÀÀÔü
  • cell inclusion
    ¼¼Æ÷Æ÷ÇÔ¹°, ¼¼Æ÷ºÀÀÔü
  • epidermal inclusion cyst
    Ç¥ÇǺÀÀÔ³¶, Ç¥ÇÇÆ÷ÇÔ³¶
  • germinal inclusion cyst
    ¹è»óÇǺÀÀÔ³¶, ¹è»óÇÇÆ÷ÇÔ¹°³¶
  • hyaline inclusion
    À¯¸®ÁúÆ÷ÇÔ¹°, À¯¸®ÁúºÀÀÔü
  • inclusion
    1. Æ÷ÇÔ¹°, ºÀÀÔü 2. ºÀÀÔ
  • inclusion blennorrhea
    ºÀÀÔü°í¸§´«¹°, ºÀÀÔü³ó·ç
  • inclusion body
    Æ÷ÇÔü, ºÀÀÔü
  • inclusion body fibromatosis
    Æ÷ÇÔü¼¶À¯Á¾Áõ, ºÀÀÔü¼¶À¯Á¾Áõ
  • inclusion cast
    Æ÷ÇÔü¿øÁÖ
  • inclusion cyst
    Æ÷ÇÔ¹°³¶, ºÀÀÔ³¶
  • inclusion disease
    Æ÷ÇÔüº´, ºÀÀÔüº´
  • inclusion/exclusion criteria
    Æ÷ÇÔÁ¦¿Ü±âÁØ
  • intracellular inclusion body
    ¼¼Æ÷³»Æ÷ÇÔü, ¼¼Æ÷³»ºÀÀÔü
  • intranuclear inclusion body
    ÇÙÆ÷ÇÔü, ÇÙ³»ºÀÀÔü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inclusion body fibromatosis
    Æ÷ÇÔü¼¶À¯Á¾Áõ
  • hyaline inclusion
    À¯¸®ÁúÆ÷ÇÔ¹°, À¯¸®ÁúºÀÀÔü
  • inclusion
    Æ÷ÇÔ¹°
  • viral inclusion
    ¹ÙÀÌ·¯½ºÆ÷ÇÔ¹°
  • autonomous nuclear family
    ÀÚÀ²ÇÙ°¡Á·
  • nuclear bag
    ÇÙÁÖ¸Ó´Ï
  • nuclear bombardment
    ÇÙÃæ°Ý
  • nuclear cardiology
    ½ÉÀåÇÙÀÇÇÐ
  • nuclear chain
    Çٻ罽
  • nuclear dust
    ÇÙ¸ÕÁö
  • nuclear energy
    ÇÙ¿¡³ÊÁö
  • nuclear envelope
    ÇÙ¸·
  • nuclear feeling
    Çٽɰ¨Á¤
  • nuclear fission
    Çٺп­
  • nuclear bag fiber
    ÇÙÁָӴϼ¶À¯, ÇÙÁָӴϱÙÀ°¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inner nuclear layer
    ³»°ú¸³Ãþ(Ò®öµ), ¼ÓÇÙÃþ.
  • progressive nuclear ophthalmoplegia
    ÁøÇ༺ÇÙ¼º¾È±Ù¸¶ºñ.
  • progressive nuclear ophthalmoplegia
    ÁøÇ༺ ÇÙ¼º ¾È±Ù¸¶ºñ(òäú¼àõ ú·àõ äÑÐÉØ¦Ýö)
  • progressive nuclear ophthalmoplegia
    ÁøÇ༺ÇÙ¼º¾È±Ù¸¶ºñ
  • acute inclusion body encephalitis
    ±Þ¼º ºÀÀÔü³ú¿°(¡­Üæìýô÷Òàæú).
  • inclusion blennorrhea
    ºÀÀÔü³ó·ç¾È.
  • inclusion body
    ºÀÀÔü
  • inclusion body disease
    ºÀÀÔüº´.
  • inclusion body fibromatosis
    ºÀÀÔü ¼¶À¯Á¾Áõ
  • inclusion body myositis
    ºÀÀÔü ±Ù¿°(¡­ÐÉæú)
  • inclusion body, cytoplasmic
    ¼¼Æ÷Áú³» ºÀÀÔü
  • inclusion body, intracytoplasmic
    ¼¼Æ÷³»ºÀÀÔü
  • inclusion cast
    ºÀÀÔü¿øÁÖ
  • inclusion conjunctivities
    ºÀÀÔü °á¸·¿°(¡­Ì¿Ø¯æú)
  • inclusion conjunctivitis
    ºÀÀÔü°á¸·¿°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • leukemia,auer bodies or rods
    ¾Æ¿ì¿¡¸£ ¼Òü(á³ô÷) ¶Ç´Â ¾Æ¿ì¿¡¸£ °£
  • negri bodies
    ³×±×¸®¼Òü ±¤°ßº´ºÀÀÔ¼Òü(ÎÊÌ³Ü»Üæìýá³ô÷)
  • picks bodies
    ÇÇÅ©¼Òü(¡­á´ô÷)
  • quadrigeminal bodies
    ȍ
  • quadrigeminal bodies
    »ç±¸Ã¼(ÞÌÎøô÷).
  • removal of foreign bodies in root canal
    ±Ù°ü³»À̹°Á¦°Å¹ý(ÐÆÎ·Ò®ì¶Úªð¶ËÛ Ûö).
  • rheumatic fever,aschoff bodies
    ¾Æ¼îÇÁ¼Òü(¾Æ¼îÇÁ á³ô÷)
  • sickel cell disease,gandy gamna bodies
    °µµð°¨³ª¼Òü(¡­á³ô÷)
  • acute inclusion body encephalitis
    ±Þ¼º ºÀÀÔü³ú¿°(¡­Üæìýô÷Òàæú).
  • body, inclusion
    ºÀÀÔü
  • conjunctivits, inclusion
    ºÀÀÔü °á¸·¿°
  • crystalloid inclusion
    °áÁ¤Æ÷ÇÔ¹°
  • cytomegalic inclusion
    °Å´ë¼¼Æ÷ºÀÀÔü(ËÝÓÞá¬øàÜæìýô÷)
  • cytomegalic inclusion disease
    ¼¼Æ÷ °Å´ë ºÀÀÔü º´
  • cytomegalic inclusion disease
    ¼¼Æ÷°Å´ëÈ­ ºÀÀÔüº´
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Nuclear saccule
    ÇÙÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ÇÙ¼Ò³¶
  • Nuclear bag fiber
    ÇÙÁָӴϱÙÀ°¼¼Æ÷
    [¿¾ ¿ë¾î] ÇÙ³¶
  • Nuclear phenomena
    ÇÙÇö»ó
    [¿¾ ¿ë¾î] ÇÙ»ó
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • nuclear resonance scattering
    ÇÙ°ø¸íºÐ»ê(ú·ÍìÙ°ÝÂߤ)
  • nuclear zone
    ÇÙ¿ª(ú·æ´)
  • small nuclear RNA
    ¼Ò(á³) ÇÙ(ú·)RNA
  • small nuclear ribonucleoprotein
    ¼Ò(á³) ÇÙ(ú·) ¶óÀ̺¸ÇÙ»ê´Ü¹éÁú(ú·ß«Ó±ÛÜòõ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CID   1) Carpal Instability Dissociative; ÇØ¸®¼º ÁÖ±Ù°üÀý ºÒ¾ÈÁ¤¼º
  2) Cytomegalic Inclusio...
AIE acute inclusion-body encephalitis; acute infectious encephalitis; acute infective endocarditis
BII beat inclusion index; Billroth II [operation]; butanol-insoluble iodine
CIBHA congenital inclusion-body hemolytic anemia
CID cellular immunodeficiency; charge injection device; chick infective dose; combined immunodeficiency ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
IBH Inclusion Body Hepatitis
IBM Inclusion body myositis
LBHI Lewy body-like hyaline inclusion
S-IBM Sporadic inclusion body myositis
CI cylindrical inclusion
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Leishman-Donovan bodies
    ·¹½´¸¸-µµ³ë¹Ýü
    Ä®¶ó-¾ÆÀÚ¸£ º´¿¡ °É¸° ȯÀÚÀÇ Æ¯È÷ ºñÀå°ú °£ÀÇ ¼¼¸Á ³»ÇÇ ¼¼Æ÷ ³»¿¡¼­ °üÂûµÇ´Â ±¸Çü ¶Ç´Â ³­ÇüÀÇ ¼Òü·Î¼­, ÀÌ º´À» ÀÏÀ¸Å°´Â ±â»ýÃæÀÎ ¿ø»ýµ¿¹°ÀÇ ¹«Æí¸ð ¼¼Æ÷ ³»¿¡ ÀÖ´Ù. ¶ÇÇÑ ÇǺμº ·¹½´¸¶´Ï¾ÆÁõ¿¡¼­ ´ë½Ä ¼¼Æ÷³»¿¡¼­µµ °üÂûµÈ´Ù. L. tro
  • Mooser bodies
    ¹«¿ì¼­ ¼Òü
    ¹ßÁøÆ¼Çª½ºÀÇ ¾î¶² Çü¿¡ À־ Ãʸ· »óÇÇ ¼¼Æ÷ÀÇ »ïÃâ¾×¿¡¼­ °üÂûµÇ´Â ¸®ÄÉÄ¡¾Æ ¸ð¾çÀÇ ¼Òü.
  • Nissl bodies
    ´Ï½½ ¼Òü
    »ö¼Ò ģȭü, ŸÀ̱׷ÎÀÌµå ¹°Áú, Ç¥¹® ¹°Áú. ¿°±â¼º ¿°·á·Î ¿°»öµÇ°í, ³»ÇüÁú ¼¼¸Á°ú ¶óÀ̺¸¼ØÀ¸·Î ±¸¼ºµÈ ½Å°æ ¼¼Æ÷³»ÀÇ Ä¿´Ù¶õ °ú¸³.
  • purine bodies test
    Ǫ¸°Ã¼ ½ÃÇè
  • rice bodies
    ¹Ì¸³Ã¼
    °üÀý°ÇÀ̳ª ¼öȰ¾× ³¶Á¾¾× ¼Ó¿¡ Çü¼ºµÇ´Â ¹Ì¸³»óÀÇ ¼Òü.
  • Schaumann's bodies
    »þÀ¯¸¸Ã¼
    Àû»öÀÌ µµ´Â °¥»öÀÇ °áÀý»ó ¶Ç´Â Á¶°³ ¸ð¾çÀÇ »ç¸£ÄÚÀ̵µ½Ã½º º´º¯¿¡¼­ °üÂûÇÒ ¼ö ÀÖ´Â ¼Òü.
  • ultimobranchial bodies
    ÈÄ»õü
    Á¦ 5Àεγ¶ ȤÀº »õ³¶ÀÇ ¹èÀ¯µµÃ¼·Î¼­, ºÎ°©»ó¼±À» ¿¬ÇÏ¿© °©»ó¼±°ú À¶ÇÕÇÑ´Ù.
  • vermiform bodies
    Ãæ¾ç ¼Òü
    °£ÀÇ ÄíÆÛ ¼¼Æ÷¿¡¼­ º¼ ¼ö ÀÖ´Â ¼¼Æ÷¸·ÀÇ Æ¯ÀÌÇÑ µ¿ ¸ð¾çÀÇ ÇÔ¸ô·Î¼­ ÆòÇื°ú Èñ¹ÌÇÑ È¾¹® »çÀÌ¿¡ Áß¾Ó ¼±»ó ±¸Á¶¸¦ °¡Áö°í ÀÖ´Ù. ÀÌ¿Í À¯»çÇÑ ±¸Á¶¸¦ ¾î¶² Àå±â³»ÀÇ ´ë½Ä¼¼Æ÷¿Í Ç¥ÇÇÀÇ ¶û°Ô¸£Çѽº ¼¼Æ÷¿¡¼­µµ °üÂûÇÒ ¼ö ÀÖ´Ù.
  • free nuclear division
    À¯¸® ÇÙ ºÐ¿­
    ¼¼Æ÷Áúü ºÐ¿­À» ¼ö¹ÝÇÏÁö ¾Ê°í ÀÌ·ç¾îÁö´Â ÇÙ ºÐ¿­. ÀÚÀ¯ ÇÙ ºÐ¿­À̶ó°íµµ ÇÑ´Ù. À¯¸® ÇÙ ºÐ¿­ °á°ú ÀϽÃÀûÀ¸·Î ´ÙÇÙ ¼¼Æ÷°¡ Çü¼ºµÇÁö¸¸, ±× ÈÄ µ¿½Ã¿¡ ÇÙ »çÀÌ °Ýº®ÀÌ Çü¼ºµÇ¾î ´Ù¼öÀÇ ¼¼Æ÷·Î ºÐ¸®µÈ´Ù. °Ñ¾¾½Ä¹°ÀÇ ¹è Çü¼º, Á¾ÀÚ ½Ä¹°ÀÇ ¹èÁ¥ Çü¼º, °üÁ¶·ùÀÇ ¿µ¾çü µî¿¡¼­ º¼ ¼ö ÀÖ´Ù. °ïÃæÀÇ ³­ÇÒ ÃʱâÀÇ °úÁ¤µµ À̰Ϳ¡ ÇØ´çÇÑ´Ù.
  • net nuclear magnetization
    ÃÑ ÇÙ ÀÚ±âÈ­
  • nuclear
    ÇÙÀÇ, ¿øÀÚ ÇÙÀÇ
  • nuclear antigen
    ÇÙ Ç׿ø
  • nuclear bag fiber
    ÇÙ ³¶ ¼¶À¯
  • nuclear bombardment
    ÇÙ Ãæµ¹
  • nuclear cataract
    ÇÙ ¹é³»Àå
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
inclusion body myositis <radiology> Common form of inflamatory myopathy, most common in the elderly, equal sex incidence, sporadic idiopathic disease (very rarely familial), misdiagnosed as steroid-resistant polymyositis symptoms, presents as a painless slowly progressive proximal myopathy, may cause dysphagia, mild to moderate muscle wasting diagnosis, serum creatine kinase levels usually normal or only slightly elevated, EMG may show non-specific myopathic features, diagnosis on muscle biopsy, inclusion bodies seen in rimmed vacuoles in skeletal muscle fibres treatment, steroids and immunosuppression generally ineffective, rare patients reported who have made a response to treatment pathogenesis, unknown, ubiquitin, prion protein, tau protein found in inclusions, abnormal mitchondria seen in some case
(12 Dec 1998)
inclusion body rhinitis A respiratory disease of pigs caused by the cytomegalovirus porcine herpesvirus 2 and characterised by rhinitis and conjunctivitis in young pigs.
(05 Mar 2000)
inclusion cell i cell
inclusion cell disease <biochemistry> Mucolipidosis of early onset and with severe symptoms like those in Hurler's syndrome but with normal urinary mucopolysaccharides, vacuolated lymphocytes, and inclusion bodies in cultured fibroblasts (I-cells).
The lysosomes lack hydrolases but high concentrations of lysosomal enzymes are found in the extracellular fluids such as serum, spinal fluid, and urine.
It is associated with a deficiency of N-acetylglucosaminyl-1-phosphotransferase. The gene defect responsible probably prevents the addition of the lysosome recognition marker mannose 6 phosphate) to these enzymes so that they are not directed into the lysosomes but are released.
Inheritance: autosomal recessive.
Synonym: I-cell disease, inclusion cell disease.
(12 Jul 2000)
inclusion compound The mechanical trapping of small molecules within spaces between other molecules; e.g., the inclusion of iodine molecules by starch molecules to form the well-known red-to-black "addition compound"
(05 Mar 2000)
inclusion conjunctivitis A follicular conjunctivitis caused by Chlamydia trachomatis.
(05 Mar 2000)
inclusion conjunctivitis viruses Former name for Chlamydia trachomatis.
(05 Mar 2000)
inclusion cyst Intradermal or subcutaneous saclike structure, the wall of which is stratified epithelium containing keratohyalin granules.
(12 Dec 1998)
inclusion dermoid A collection of cancerous cells which form cysts that contain one or more of the three primary embryonic germ layers: skin, hair or teeth.
(27 Sep 1997)
epidermoid inclusion cyst <radiology> Well-circumscribed radiolucent lesion showing a thin cortical margin that may not be visible in its entirety, frequently in the terminal phalanx, history of penetrating trauma is often elicited Differential diagnosis: ABC, enchondroma
(12 Dec 1998)
foetal inclusion Unequal conjoined twins in which the incompletely developed parasite is wholly enclosed in the autosite.
(05 Mar 2000)
receptors, cytoplasmic and nuclear Proteins in the cytoplasm or nucleus that specifically bind signalling molecules and trigger changes which influence the behaviour of cells. The major groups are the steroid hormone receptors, which usually are found in the cytoplasm, and the thyroid hormone receptors, which usually are found in the nucleus. Receptors, unlike enzymes, generally do not catalyze chemical changes in their ligands.
(12 Dec 1998)
Remak's nuclear division <cell biology> An unusual form of nuclear division, in which the nucleus simply constricts, rather like a cell without chromosome condensation or spindle formation. Partitioning of daughter chromosomes is haphazard. Observed in some Protozoa.
(18 Nov 1997)
Pelger-Huet nuclear anomaly Congenital inhibition of lobulation in the nuclei of neutrophilic leukocytes; most cells present band or bilobulate appearance, and only an occasional cell is trilobed; it is not associated with disease, but may be confused with leukocyte "shift to left"; autosomal dominant inheritance.
(05 Mar 2000)
ribonucleoproteins, small nuclear Highly conserved nuclear RNA-protein complexes that function in RNA processing in the nucleus, including pre-mRNA splicing and pre-mRNA 3'-end processing in the nucleoplasm. The u3 snrnp is localised in the nucleolus, where it aligns into base pairs with the 28s rrna precursor in a still unidentified region and functions in pre-rrna processing. The u7 snrnp aligns into base pairs with a conserved sequence in the 3'-end of histone pre-mRNA and is an essential cofactor for the cleavage that creates the mature nonadenylated 3'-end.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • nuclear grapeshot
    (±º)¼ÒÇü Àü¼úÇÙ¹«±â
  • nuclear magnetic resonance
    (¹°)ÇÙÀڱ⠰ø¸í
  • nuclear medicine
    (ÀÇ)ÇÙÀÇÇÐ(¹æ»ç¼± ÇÙÁ¾À» ÀÌ¿ëÇÏ´Â ÀÓ»óÀÇÇÐ)
  • nuclear membrane
    (»ý)ÇÙ¸·
  • nuclear molecule
    (¹°)¿øÀÚÇÙ ºÐÀÚ
  • nuclear nonproliferation
    ÇÙÈ®»ê ¹æÁö
  • nuclear physicist
    ¿øÀÚ ¹°¸®ÇÐÀÚ
  • nuclear physics
    (¿øÀÚ)ÇÙ ¹°¸®ÇÐ
  • nuclear plant
    ¿øÀÚ·Â ¹ßÀü¼Ò
  • nuclear power
    (µ¿·ÂÀ¸·Î¼­ÀÇ)¿øÀÚ·Â;ÇÙ¹«±â º¸À¯±¹
  • nuclear powered
    ¿øÀÚ·ÂÀ» µ¿·ÂÀ¸·Î ÇÏ´Â(Àá¼öÇÔµî)
  • nuclear reaction
    ÇÙ¹ÝÀÀ
  • nuclear reactor
    ¿øÀÚ·Î
  • nuclear resonance
    ÇÙ°ø¸í
  • nuclear shelter
    ÇÙ´ëÇǼÒ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á